Evidence map›Paper›PMID 36551276›Full record

ReviewBiomolecules2022

Degradation Mechanism of AAA+ Proteases and Regulation of

Weifeng Xu, Wenli Gao, Qingting Bu, Yongquan Li

Open access · goldAbstract readReview
In one paragraph

Review in Biomolecules, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Weifeng XuInstitute of Pharmaceutical Biotechnology, Zhejiang University School of Medicine, Hangzhou 310058, China.
Wenli GaoInstitute of Pharmaceutical Biotechnology, Zhejiang University School of Medicine, Hangzhou 310058, China.
Qingting BuInstitute of Pharmaceutical Biotechnology, Zhejiang University School of Medicine, Hangzhou 310058, China.
Yongquan LiInstitute of Pharmaceutical Biotechnology, Zhejiang University School of Medicine, Hangzhou 310058, China.ORCID 0000-0001-6013-4068
Zhejiang University · CN

Funding

National Key R&D Program of China 2019YFA09005400National Natural Science Foundation of China 31730002
6 · The paper itself

Abstract

Hundreds of proteins work together in microorganisms to coordinate and control normal activity in cells. Their degradation is not only the last step in the cell's lifespan but also the starting point for its recycling. In recent years, protein degradation has been extensively studied in both eukaryotic and prokaryotic organisms. Understanding the degradation process is essential for revealing the complex regulatory network in microorganisms, as well as further artificial reconstructions and applications. This review will discuss several studies on protein quality-control family members Lon, FtsH, ClpP, the proteasome in

Indexed as

ATPases Associated with Diverse Cellular ActivitiesProteasome Endopeptidase ComplexProteolysisStreptomycesATPases Associated with Diverse Cellular ActivitiesProteasome Endopeptidase ComplexClpPFtsHLonproteasomeprotein degradationregulatory networkStreptomyces

Identifiers

PMID36551276
PMCPMC9775585
OpenAlexW4312125593

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.